10-Q 1 ammj11101610q.htm

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

 

FORM 10-Q

 

(Mark One)

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2016.

 

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from ______ to ______.

 

 

Commission File Number 000-26108

 

AMERICAN CANNABIS COMPANY, INC.

(Exact name of registrant as specified in its charter)

       
Delaware
(State or other jurisdiction of
incorporation or organization)		     94-2901715
(I.R.S. Employer
Identification No.)

 

5690 Logan St. Unit A
Denver, Colorado
(Address of principal executive offices)

    

 

80216
(Zip Code)

(303) 974-4770
(Registrant's telephone number, including area code)

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [ X]   No [ ]

 

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes [X]    No [ ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of "large accelerated filer," "accelerated filer" and "smaller reporting company" in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer [ ]   Accelerated filer [ ]   Non-accelerated filer [ ]
 (Do not check if a
smaller reporting company)		   Smaller reporting company [X]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). 

Yes [ ]   No [X] 

 

On November 14, 2016, 46,801,074 shares of common stock were outstanding.   

 
 



 TABLE OF CONTENTS

 

  PART I. FINANCIAL INFORMATION Page
     
Item 1. FINANCIAL STATEMENTS (Unaudited): 1
     
  CONDENSED CONSOLIDATED BALANCE SHEETS AS OF SEPTEMBER 30, 2016 AND DECEMBER 31, 2015. 1
     
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2016 AND 2015. 2
     
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2016 AND SEPTEMBER 30, 2015. 3
     
  NOTES TO THE UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS. 4
     
Item 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS 10
     
Item 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK 17
     
Item 4. CONTROLS AND PROCEDURES 18
     
  PART II. OTHER INFORMATION  
     
Item 1. LEGAL PROCEEDINGS 19
     
Item 1A. RISK FACTORS 19
     
Item 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS 19
     
Item 3. DEFAULTS UPON SENIOR SECURITIES 16
     
Item 5. OTHER INFORMATION 19
     
Item 6. EXHIBITS 20
     
SIGNATURES   21

 
 

PART I—FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED  BALANCE SHEETS

(Unaudited) 

 

    September 30, 2016    December 31, 2015 
ASSETS          
Current Assets          
       Cash and equivalents  $71,572   $555,780 
Accounts receivable, net of allowance $55,573 and $8,419, respectively   185,754    48,285 
       Deposits   6,500    9,345 
       Inventory   67,197    67,435 
       Prepaid expenses and other current assets   48,267    32,117 
Total Current Assets   379,290    712,962 
           
Property and equipment - net   12,994    13,448 
           
       Other Assets   4,500    4,500 
           
TOTAL ASSETS   396,784    730,910 
           
LIABILITIES AND SHAREHOLDERS’ EQUITY           
Current Liabilities          
       Accounts payable   101,130    218,334 
       Advances from clients   278,292    220,966 
       Convertible note, net of discount of $0 and $11,248, repectively   150,000    60,252 
       Accrued and other current liabilities   11,182    93,468 
Total Current Liabilities   540,604    593,020 
           
Total Liabilities   540,604    593,020 
           
Commitments and contingencies          
           
Shareholders’ Equity           
Common stock, $0.00001 par value;  100,000,000 shares authorized; 46,751,074 and 44,808,731 issued and outstanding at September 30, 2016 and December 31, 2015, respectively   465    448 
Additional paid-in capital   4,355,257    4,268,708 
Accumulated deficit   (4,499,542)   (4,131,266)
Total Shareholders’ equity   (143,820)   137,890 
           
TOTAL LIABILITIES AND SHAREHOLDERS’ DEFICIT  $396,784   $730,910 

 

 

AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENT OF OPERATIONS

(UNAUDITED)

 

   For the three months ended September 30,  For the nine months ended September 30,
   2016  2015  2016  2015
Revenues                    
     Consulting Services  $143,610   $143,072   $603,083   $607,130 
     Product and equipment   93,290    200,057    617,869    648,411 
Total Revenues   236,900    343,129    1,220,952    1,255,541 
                     
Cost of Revenues                    
     Cost of consulting services   38,120    79,245    137,920    295,659 
     Cost of products and equipment   66,614    190,547    447,470    592,545 
Total Cost of Revenues   104,734    269,792    585,390    888,204 
                     
Gross Profit   132,166    73,337    635,562    367,337 
                     
Operating expenses                    
     General and administrative   353,292    159,145    884,733    341,792 
     Investor Relations   11,129    14,924    29,197    202,626 
     Selling and marketing   22,855    73,950    63,332    281,479 
     Research and development   520    8,404    1,932    50,126 
Total Operating expenses   387,796    256,423    979,194    876,023 
                     
Income (Loss) from Operations   (255,630)   (183,086)   (343,632)   (508,686)
                     
Other Income (expense)                    
    (Loss) Gain on debt extinguishment   (59,128)   —    (59,128)   72,771 
    Change in derivative Liabilities   64,419    —    64,419    — 
     Interest (expense)   (19,605)   (8,924)   (29,935)   (26,547)
Total Other Income (expense)   (14,314)   (8,924)   (24,644)   46,224 
                     
Net Income (Loss) before taxes   (269,944)   (192,010)   (368,276)   (462,462)
                     
NET INCOME (LOSS)  ($269,944)  ($192,010)  ($368,276)  ($462,462)
                     
Basic and diluted net loss per common share *  ($0.01)  ($0.00)*  ($0.01)  ($0.01)
                     
Basic and diluted weighted average common shares outstanding   46,673,272    45,702,876    45,979,352    45,348,984 

 

* denotes a loss of less than $(0.01).

 

The accompanying notes are an integral part of these audited consolidated financial statements                                 

 

 

AMERICAN CANNABIS COMPANY, INC.

CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE NINE MONTHS ENDED SEPTEMBER 30, 2016 AND 2015

(UNAUDITED)

 

   2016  2015
CASH FLOWS FROM OPERATING ACTIVITIES:          
Net loss  $(368,276)  $(462,462)
Adjustments to reconcile net loss) to net cash (used in )          
operating activities:          
  Bad debt expense   66,431    6,015 
  Depreciation   3,744    2,435 
  Amortization of discount on convertible notes payable   26,302    26,703 
  Stock-based compensation to employees   16,240    102,857 
  Stock-based compensation to service providers   9,198    146,655 
  Change in Derivative liabilities   (64,419)     
  Loss (Gain) on debt extinguishment   59,128    (72,771)
  Changes in operating assets and liabilities          
     Accounts receivables   (203,900)   (138,156)
     Deposits   2,845    (193,794)
     Inventory   238    (67,847)
     Prepaid expenses and other current assets   (16,150)   (15,066)
     Advances from clients   57,326    676,144 
     Accrued and other current liabilities   (91,484)   (1,993)
     Accounts payable   (117,206)   89,472 
Net Cash (used in) provided by Operating Activities   (619,983)   98,192 
           
CASH FLOWS FROM INVESTING ACTIVITIES:          
  Purchases of property and equipment   (3,290)   (24,583)
Net Cash Used in Investing Activities   (3,290)   (24,583)
           
CASH FLOWS FROM FINANCING ACTIVITIES          
  Proceeds from convertible notes   139,065    —  
  Proceeds from issuance of common shares   —    250,000 
Net Cash Provided by Financing Activities   139,065    250,000 
           
NET (DECREASE) INCREASE IN CASH   (484,208)   323,609 
           
CASH AT BEGINNING OF PERIOD   555,780    165,213 
           
CASH AT END OF PERIOD  $71,572   $488,822 
           
           
Supplemental disclosure of cash flow information:          
  Cash paid during the period for interest   $—    $(155)
  Cash paid (received) during the period for income taxes, net   $—    $—   
Non-Cash Investing and financing activities          
   Conversion of notes payable to shares of common stock  $71,500   $—   

           

The report on the financial statements and accompanying notes are an integral part of these financial statements.

 

 

AMERICAN CANNABIS COMPANY, INC.

NOTES TO THE CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FOR THE THREE AND NINE MONTHS ENDED SEPTEMBER 30, 2016 and 2015
(Unaudited)

 

Note 1. Description of the Business

 

American Cannabis Company, Inc. and its subsidiary Company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. The Company provides advisory and consulting services specific to this industry, manufactures proprietary industry solutions including; the Satchel™, SoHum Living Soils™, Cultivation Cube™ and the High Density Cultivation System.™ The Company also sells 3rd party industry-specific products and manages a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. American Cannabis Company, Inc. is a publicly listed company quoted on the OTCQB under the symbol “AMMJ”.

 

Note 2. Summary of Significant Accounting Policies

 

Basis of Accounting

The financial statements are prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). The Company has elected a fiscal year ending on December 31. Certain balance sheet reclassifications have been made to prior period balances to reflect the current period’s presentation format; such reclassifications had no impact on the Company’s consolidated statements of operations or consolidated statements of cash flows and had no material impact on the Company’s consolidated balance sheets.

 

Reclassifications

 

Prior year amounts have been reclassified to conform to the current year presentation.

 

Use of Estimates in Financial Reporting

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the amount of assets and liabilities, and disclosures of contingent assets and liabilities, as of the date of the financial statements during the periods presented. Actual results could differ from these estimates. Estimates and assumptions are reviewed periodically, and the effects of revisions are reflected in the financial statements in the period in which they are deemed to be necessary. Significant estimates made in the accompanying financial statements include but are not limited to following: those related to revenue recognition, allowance for doubtful accounts and unbilled services, lives and recoverability of equipment and other long-lived assets, contingencies and litigation. The Company is subject to uncertainties, such as the impact of future events, economic, environmental and political factors, and changes in the business climate; therefore, actual results may differ from those estimates. When no estimate in a given range is deemed to be better than any other when estimating contingent liabilities, the low end of the range is accrued. Accordingly, the accounting estimates used in the preparation of the Company's financial statements will change as new events occur, as more experience is acquired, as additional information is obtained and as the Company's operating environment changes. Changes in estimates are made when circumstances warrant. Such changes and refinements in estimation methodologies are reflected in reported results of operations; if material, the effects of changes in estimates are disclosed in the notes to the financial statements.

 

Unaudited Interim Financial Statements

The accompanying unaudited financial statements have been prepared in accordance with U.S. GAAP for interim financial information and with the instructions to Form 10-Q and Regulation S-X.  Accordingly, the financial statements do not include all of the information and footnotes required by generally accepted accounting principles for complete financial statements. In the opinion of management, all adjustments consisting of normal recurring entries necessary for a fair statement of the periods presented for: (a) the financial position; (b) the result of operations; and (c) cash flows, have been made in order to make the financial statements presented not misleading. The results of operations for such interim periods are not necessarily indicative of operations for a full year.

 

Significant Clients and Customers

 

For the three months ended September 30, 2016, three customers individually accounted for 10% or more of the Company’s revenues; these customers accounted for approximately 41% of the Company’s total revenues for the period. For the three months ended September 30, 2015, two customers individually accounted for 10% or more of the Company’s revenues; these customers accounted for approximately 63% of the Company’s total revenues for the period.

 

For the nine months ended September 30, 2016, three customers individually accounted for 10% or more of the Company’s total revenues; these customers accounted for approximately 53.2% of the Company’s total revenues for the period. For the nine months ended September 30, 2015, three customers individually accounted for 10% or more of the Company’s total revenues; these customers accounted for approximately 68% of the Company’s total revenues for the period.

 

Beneficial Conversion Feature

If the conversion features of conventional convertible debt provides for a rate of conversion that is below market value at issuance, this feature is characterized as a beneficial conversion feature (“BCF”). A BCF is recorded by the Company as a debt discount pursuant to Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ACF”) Topic 470-20 Debt with Conversion and Other Options. In those circumstances, the convertible debt is recorded net of the discount related to the BCF, and the Company amortizes the discount to interest expense, over the life of the debt using the effective interest method.

 

Revenue Recognition

Revenue is recognized in accordance with FASB ASC Topic 605, Revenue Recognition. The Company recognizes revenue when persuasive evidence of an arrangement exists, the related services are rendered or delivery has occurred, the price is fixed or determinable and collectability is reasonably assured.

 

Net Income (Loss) Per Common Share

The Company reports net income (loss) per common share in accordance with FASB ASC 260, “Earnings per Share”. This statement requires dual presentation of basic and diluted earnings with a reconciliation of the numerator and denominator of the earnings per share computations. Basic net income (loss) per share is computed by dividing net income attributable to common stockholders by the weighted average number of shares of common stock outstanding during the period and excludes the effects of any potentially dilutive securities. Diluted net income (loss) per share gives effect to any dilutive potential common stock outstanding during the period. The computation does not assume conversion, exercise or contingent exercise of securities that would have an anti-dilutive effect on earnings.

 

Due to the Company’s net losses for the three and nine months ended September 30, 2016 and September 30, 2015, any potentially dilutive shares outstanding for these periods, respectively, were not presented in the EPS computations, as their effect would have been antidilutive.

 

Recent Accounting Pronouncements

 

The Company has reviewed all the recently issued, but not yet effective, accounting pronouncements and it does not believe any of these pronouncements will have a material impact on the Company.

 

Reclassifications

 

Prior year amounts have been reclassified to conform to the current year presentation.

 

Note 3. Accounts Receivable, net

 

Accounts receivable, net, was comprised of the following as of September 30, 2016 and December 31, 2015:

 

 

    September 30, 2016    December 31, 2015 
Gross accounts receivable   241,327    56,704 
Less: allowance for doubtful accounts   (55,573)   (8,419)
Accounts receivable, net   185,754    48,285 

 

The Company had bad debt expense during the nine months ended September 30, 2016 and 2015 of $66,431 and $6,015, respectively. During the nine months ended September 30, 2016 and 2015, the Company wrote-off old receivables and their related allowances for bad debts of $19,277 and $0, respectively.

 

Note 4. Deposits

 

Deposits were comprised of the following as of September 30, 2016 and December 31, 2015:

 

    September 30, 2016    December 31, 2015 
Attorney retainer deposits in other current assets   

6,500

    

9,345

 

Operating lease deposits in other assets

   

4,500

    

4,500

 

Deposits

   

11,000

    

13,845

 

 

Deposits as of September 30, 2016 and December 31, 2015 reflect down payments made to vendors and service providers.

 

Note 5. Inventory

 

Inventory as of September 30, 2016 and December 31, 2015 of $67,197 and $67,435, respectively, was fully comprised of finished goods.

 

Note 6. Prepaid expenses and other current assets

 

Prepaid expenses and other current assets was comprised of the following as of September 30, 2016 and December 31, 2015:

 

    September 30, 2016    December 31, 2015 

Prepaid expenses and other current assets

   

48,267

    

32,117

 

 

Note 7. Property and Equipment, net

 

Property and equipment, net, was comprised of the following as of September 30, 2016 and December 31, 2015:

 

    September 30, 2016    December 31, 2015 
Office equipment   9,277    7,472 
Furniture and fixtures   10,262    8,777 
Machinery and equipment   2,336    2,336 
Property and equipment, gross   21,875    18,585 
Less: accumulated depreciation   (8,881)   (5,137)
Property and equipment, net   12,994    13,448 

 

 

The Company recorded depreciation expense of $1,348 and $961 during the three months ended September 30, 2016 and 2015, respectively. During the nine months ended September 30, 2016 and 2015, the Company recorded depreciation expense of $3,744 and $2,435, respectively.

 

Note 8. Convertible Notes Payable

 

As of September 30, 2016 and December 31, 2015, the Company reflected convertible notes payable as follows:

 

    Principal    Loan      
    Balance    Discount    Total 
Balance as of December 31, 2015  $71,500   $(11,248)  $60,252 
Issued in the period   150,000    (10,935)   139,065 
Converted into shares of common stock   (71,500)   10,075    (61,425)
Amortization of debt discount   —    (26,302)   (26,302)
Gain on extinguishment   —    38,410    38,410 
Balance as of September 30, 2016  $150,000   $—     $150,000 

 

The Company had convertible debentures which were originally issued on April 24, 2014, maturing on April 24, 2016, paid zero interest, and were convertible until maturity at the holders’ discretion into shares of the Company’s common stock at $0.08 per share. On April 11, 2016, the maturity date on this note was renegotiated to April 24th, 2018. On April 12, 2016, the Company received notice of a partial conversion of this note in the amount of $58,000 that was converted into 725,000 shares of common stock at a price of $0.08 per share. On May 6, 2016, the Company received notice for the conversion of the balance of the note in the amount of $13,500 that was converted into 168,750 shares of common stock at a price of $0.08 per share. Based on this conversion, as of September 30, 2016, the Company had remaining convertible debentures in the total amount of $0, and any unamortized debt discount remaining on the date of conversion was amortized in full to interest expense.

 

On June 23, 2016, the Company entered into two convertible promissory notes: one for $50,000 and one for $330,000. As of the date of this filing, the Company received $150,000 in proceeds recorded a discount of $10,935. The maturity date for each note is February 14, 2017. Each note pays 8% fixed interest and was convertible at the holder’s discretion into shares of the Company’s common stock at a conversion formula used to determine the conversion price per share. On August 4, 2016, the notes were amended and restated to change the conversion formula used to determine the conversion price per share to a fixed price of $0.1135 per share and to delete a provision that provided for repayment of the notes through a separate investment agreement providing for the Company to sell its registered shares to an investor. Based on the August 4, 2016 amendment to the convertible feature of the note payable, we recognized a loss on extinguishment of debt of $59,128. In addition, we calculated the beneficial conversion valuation before and after the amendment which yielded a change in derivative liabilities of $64,419.

  

Note 9. Accrued and Other Current Liabilities

 

Accrued and other current liabilities was comprised of the following at September 30, 2016 and December 31, 2015:

 

    September 30, 2016    December 31, 2015 
Accrued payroll liabilities   2,400    18,185 
Accrual for products sold and shipped (in transit)    1,982    64,050 
Other accruals   6,800    11,233 
Accrued and other current liabilities   11,182    93,468 

 

Note 10. Related Party Transactions

 

During the nine months ended September 30, 2016, the Company incurred $26,500 of expense for accounting services payable to JDE Development LLC, a company in which Mr. Jesus M Quintero, the Company’s Chief Financial Officer, is an owner.

 

 

Note 11. Commitments and Contingent Liabilities

 

On March 1, 2016, the Company retained Brian Johnson as a consultant for an initial term of three months until May 31, 2016, and agreed to pay Mr. Johnson 10,000 shares of its restricted common stock per month for the three-month term payable on May 31, 2016, subject to adjustment for actual hours of service rendered. On September 1, 2016, the Company and Mr. Johnson agreed to an extension of the consulting engagement for an additional one-month term, ending on September 30, 2016. Mr. Johnson provided additional services and the Company issued Mr. Johnson 87,600 shares of common stock on August 25, 2016, as a final payment for services rendered from inception through September 30, 2016 at a value of $9,198.

 

On January 20, 2016, the Company was named as a defendant in a civil suit entitled: Anthony Baroud vs. Hollister & Blacksmith, Inc., dba American Cannabis Company filed in the Circuit Court of Cook County, Illinois. The lawsuit sought damages of $100,000 related to an employment contract. The Company filed a motion to dismiss the case based upon the employment contract, which required mandatory contractual arbitration of disputes. On May 18, 2016 the Circuit Court of Cook County, Illinois granted the Company’s motion and the case was dismissed. On November 1, 2016, the Company received notice of a demand for arbitration filed with the American Arbitration Association by Mr. Baroud on October 27, 2016. The Company has yet to receive a copy of Mr. Baroud’s arbitration claim.

 

Note 12. Stock-based Compensation

 

Warrants

 

As of September 30, 2016 and December 31, 2015, the Company issued fully-vested warrants to the Company’s independent board member to purchase up to two hundred and fifty thousand (250,000) shares of common stock at an exercise price of sixty-three cents ($0.63) per share were outstanding, exercisable within five (5) years of the date of issuance on November 19, 2014. The grant date fair value of the warrants, as calculated based on the Black-Scholes valuation model, was $0.59 per share. There were no outstanding unvested warrants or new issuances of warrants during the nine months ended September 30, 2016; consequently, no stock-based compensation expense associated with warrants was recorded during the nine months ended September 30, 2016.

 

As of September 30, 2016 and December 31, 2015, as the exercise price per share exceeded the price per share of our common shares, there was no aggregate intrinsic value of outstanding warrants. As of September 30, 2016 and December 31, 2015, the warrants had 3.6 and 3.3 years remaining until expiration, respectively. No warrants were issued or outstanding during or preceding the nine months ended September 30, 2016. 

 

Stock Options

 

In addition to the warrants as described above, the Company’s independent board member shall be eligible to receive options for 400,000 shares of common stock under the Company’s incentive plan, as and when duly approved by the Board of Directors.

 

Stock Issuable in Compensation for Professional Services

 

From time to time, the Company enters into agreements whereby a professional service provider will be compensated for services rendered to the Company by shares of common stock in lieu of cash.

 

 

Note 13. Stockholders’ Equity

 

Preferred Stock

 

American Cannabis Company, Inc. is authorized to issue 5,000,000 shares of preferred stock at $0.01 par value. No shares of preferred stock were issued and outstanding during the six months ended September 30, 2016 and 2015, respectively.

 

Common Stock

 

American Cannabis Company, Inc. is authorized to issue 100,000,000 common shares at $0.00001 par value per share.

  

Note 14. Subsequent Events

 

On August 4, 2016, the Company amended and restated its material definitive investment agreement dated June 23, 2016 with Tangiers Global, LLC, a Wyoming Limited Liability Company. Tangiers agreed to invest up to five million dollars ($5,000,000) to purchase the Company’s Common Stock, subject to the Company’s agreement to provide certain registration rights under the Securities Act of 1933, as amended, concerning the Common Stock underlying Tangiers’ investment agreement. On September 12, 2016 the Company filed a registration statement on Form S-1 to register the Common Stock underlying Tangiers’ investment agreement. On November 8, 2016, the SEC issued a Notice of Effectiveness for the registration of the Common Stock.

 

On October 26, 2016, the Company issued 50,000 shares of its restricted common stock to an employee as compensation based upon an employment contract and performance review.

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

The statements contained in this report that are not statements of historical fact, including without limitation, statements containing the words “believes,” “expects,” “anticipates” and similar words, constitute forward-looking statements that are subject to a number of risks and uncertainties. From time to time we may make other forward-looking statements. Investors are cautioned that such forward-looking statements are subject to an inherent risk that actual results may materially differ as a result of many factors, including the risks discussed from time to time in this report, including the risks described under “Risk Factors” in any filings we have made with the SEC.

 

Our discussion and analysis of our financial condition and results of operations are based upon our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses. On an on-going basis, we evaluate these estimates, including those related to useful lives of real estate assets, cost reimbursement income, bad debts, impairment, net lease intangibles, contingencies and litigation. We base our estimates on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. There can be no assurance that actual results will not differ from those estimates.

 

Background

 

American Cannabis Company, Inc. and subsidiary company, Hollister & Blacksmith, Inc., doing business as American Cannabis Consulting (“American Cannabis Consulting”), (collectively “the “Company”, “we”, “us”, or “our”) are based in Denver, Colorado and operate a fully-integrated business model that features end-to-end solutions for businesses operating in the regulated cannabis industry in states and countries where cannabis is regulated and/or has been de-criminalized for medical use and/or legalized for recreational use. The Company provides advisory and consulting services specific to this industry, manufactures proprietary industry solutions including; the Satchel™, SoHum Living Soils™, Cultivation Cube™ and the High Density Cultivation System.™ The Company also sells 3rd party industry-specific products and manages a strategic group partnership that offers both exclusive and non-exclusive customer products commonly used in the industry. American Cannabis Company, Inc. is a publicly listed company quoted on the OTCQB under the symbol “AMMJ”.

 

We were incorporated in the State of Delaware on September 24, 2001 under the name Naturewell, Inc. to develop and market clinical diagnostic products using immunology and molecular biologic technologies.

 

 

 

Results of Operations 

 

For the three months ended September 30, 2016 compared to three months ended September 30, 2015.

 

The following table presents our consolidated operating results for the three months ended September 30, 2016 compared to the three months ended September 30, 2015:

 

  For the three months ended  September 30, 2016  % of Revenues  For the three months ended  September 30, 2015  % of Revenues  $ Change
 Revenues                         
      Consulting Services  $143,610    60.6   $143,072    41.7   $538 
      Product and equipment   93,290    39.4    200,057    58.3    (106,767)
 Total Revenues   236,900    100.0    343,129    100.0    (106,229)
 Cost of Revenues                         
      Cost of consulting services   38,120    16.1    79,245    23.1    (41,125)
      Cost of products and equipment   66,614    28.1    190,547    55.5    (123,933)
 Total Cost of Revenues   104,734    44.2    269,792    78.6    (165,058)
 Gross Profit   132,166    55.8    73,337    21.4    58,829 
 Operating expenses                         
      General and administrative   353,292    149.1    159,145    46.4    194,147 
      Investor Relations   11,129    4.7    14,924    4.3    (3,795)
      Selling and marketing   22,855    9.6    73,950    21.6    (51,095)
      Research and development   520    0.2    8,404    2.4    (7,884)
 Total Operating Expenses   387,796    163.7    256,423    74.7    131,373 
 Loss from Operations   (255,630)   (107.9)   (183,086)   (53.4)   (72,544)
Other Income (Expense)                         
      (Loss) Gain on debt extinguishment   (59,128)   (25.0)   —      —      (59,128)
      Change in Derivative liabilities   64,419    27.2    —      —      64,419 
      Interest (expense)   (19,605)   (8.3)   (8,924)   (2.6)   (10,681)
 Total Other Income (expense)   (14,314)   (6.0)   (8,924)   (2.6)   (5,390)
 Net loss before taxes   (269,944)   (113.9)   (192,010)   (56.0)   (77,934)
 Income tax expense (benefit)   —      —      —      —      —   
 NET LOSS  $(269,944)   (113.9)  $(192,010)   (56.0)  $(77,934)

 

 

Revenues 

Total revenues were $236,900 for the three months ended September 30, 2016 as compared to $343,129 for the three months ended September 30, 2015, a decrease of $106,229. Although consulting service revenues remain steady for the three months ended September 2016, $143,610 or 60.6% of total revenues, versus $143,072 or 41.7% of total revenues for the three months ended September 30, 2015, we experienced a decrease in our product and equipment revenues as amounts for the three months ended September 30, 2016 were $93,290 or 39.4% of total revenues, versus $200,057 or 58.3% of total revenues for three months ended September 30, 2015. This decrease was attributed to the lifecycle of client contracts with the company experiencing spikes in product revenues during facility build-outs. The company was not performing any facility build-outs for the three months ended September 30, 2016, while two facility build-outs were in-progress during the three months ended September 30, 2015.

 


Costs of Revenues 

Costs of revenues primarily consist of labor, travel, and other costs directly attributable to providing services or products. During the three months ended September 30, 2016, our total costs of revenues were $104,734, or 44.2% of total revenues. This compares to total costs of revenues for the three months ended September 30, 2015 of $269,792 or 78.6% of total revenues. The decrease in costs of revenues of $165,058 was primarily due to the change in operating activities discussed changes in our internal infrastructure. For the three months ended September 30, 2016, consulting-related costs were $38,120, or 16.1% of total revenue, as compared to costs of $79,245, or 23.1% of revenue for the three months ended September 30, 2015. Costs associated with products and equipment were $66,614, or 28.1% of total revenue for the three months ended September 30, 2016 as compared to $190,547, or 55.5% of total revenue for the three months ended September 30, 2015. As a percentage of revenues the decrease was attributed to the lifecycle of client contracts with the company experiencing spikes in product revenues during facility build-outs. The company was not performing any facility build-outs for the three months ended September 30, 2016, while two facility build-outs were in-progress during the three months ended September 30, 2015.

 

Gross Profit

Total gross profit was $132,166 for the three months ended September 30, 2016, comprised of consulting services gross profit of $105,490 and products and equipment gross profit of $26,676. This compares to total gross profit of $73,337 for the three months ended September 30, 2015, comprised of consulting services gross profit of $63,827 and products and equipment gross profit of $9,510. These increases of $41,663 for consulting services gross profit and $17,166 for products and equipment gross profit were primarily due to growth in our client base and volume of operations and further establishment of our products and equipment offerings. As a percentage of total revenues, gross profit was 55.8% for the three months ended September 30, 2016 as compared to 21.4% for the three months ended September 30, 2015. This increase was primarily due to client state licensing approval bonuses earned by the company during the three months ended September 30, 2016.

 

Operating Expenses

Total operating expenses were $387,796, or 163.7% of total revenues for the three months ended September 30, 2016, compared to $256,423, or 74.7% of total revenues for the three months ended September 30, 2015. This increase was primarily due to an increase in general and administrative expenses as the Company has incurred higher expenses for accounting, bad debts and legal fees all attributed to costs of running a public company; the increase was also attributed to reduced labor allocations transferred out of general and administrative expenses to direct project costs (cost of revenues) for the three months ended September 30, 2016 as compared to September 30, 2015. Also, the company has reduced selling and marketing efforts due to achieving stronger brand recognition in the market place during the three months ended September 30, 2016 as compared with the three months ended September 30, 2015, which has resulted in less investment in trade shows and conferences expenses. As part of the efforts on strengthening current products and services in the market in 2016, the company incurred less research and development costs for the three months ended September 30, 2016 as compared with the three months ended September 30, 2015.

 

 

Other Income (Expense) 

Other income (expense) for the three months ended September 30, 2016 was an expense of $14,314 as compared with an expense of $8,924 for the three months ended September 30, 2015. For the three months ended September 30, 2016 the company incurred a non-cash loss on extinguishment of debt of $59,128 and also an interest expense reflecting $19,605 related to convertible notes payable discount amortization for the period, which was offset by a $64,419 gain on change in derivative liabilities for the same period. For the three months ended September 30, 2015 the company had interest expense of $8,924.

 

Net Income (Loss)

As a result of the factors discussed above, net income (expense) for the three months ended September 30, 2016 was a net loss of $269,944 or 113.9% of total revenues for the period, as compared to a net loss of 192,010, or 56.0% of total revenues for the three months ended September 30, 2015.

  

Results of Operations 

 

For the nine months ended September 30, 2016 compared to nine months ended September 30, 2015

 

The following table presents our consolidated operating results for the nine months ended September 30, 2016 compared to the nine months ended September 30, 2015:

 

 

    For the nine months ended  September 30, 2016   % of Revenues    For the nine months ended  September 30, 2015    % of Revenues    $ Change 
Revenues                        
     Consulting Services  $603,083   49.4   $607,130    48.4   ($4,047)
     Product and equipment   617,869   50.6    648,411    51.6    (30,542)
Total Revenues   1,220,952   100.0    1,255,541    100.0    (34,589)
                         
Cost of Revenues                        
     Cost of consulting services   137,920   11.3    295,659    23.5    (157,739)
     Cost of products and equipment   447,470   36.6    592,545    47.2    (145,075)
Total Cost of Revenues   585,390   47.9    888,204    70.7    (302,814)
                         
Gross Profit   635,562   52.1    367,337    29.3    268,225 
                         
Operating expenses                        
     General and administrative   884,733   72.5    341,792    27.2    542,941 
     Investor Relations   29,197   2.4    202,626    16.1    (173,429)
     Selling and marketing   63,332   5.2    281,479    22.4    (218,147)
     Research and development   1,932   0.2    50,126    4.0    (48,194)
Total Operating expenses   979,194   80.2    876,023    69.8    103,171 
                         
Loss from Operations   (343,632)  (28.1)   (508,686)   (40.5)   165,054 
                         
Other Income (expense)                        
     Gain on debt extinguishment   (59,128)  (4.8)   72,771    5.8    (131,899)
     Change in Derivative liabilities   64,419   5.3    —    —    64,419 
     Interest (expense)   (29,935)  (2.5)   (26,547)   (2.1)   (3,388)
Total Other Income (expense)   (24,644)  (2.0)   46,224    3.7    (70,868)
                         
Net Loss before taxes   (368,276)  (30.2)   (462,462)   (36.8)   94,186 
Income Tax expense (benefit)   —   —    —    —    — 
                         
NET LOSS  ($368,276)  (30.2)  ($462,462)   (36.8)  $94,186 

 

 

Revenues 

Total revenues were $1,220,952 for the nine months ended September 30, 2016 as compared to $1,255,541 for the nine months ended September 30, 2015, a decrease of $34,589. Consulting service was $603,083 or 49.4% of total revenues for the nine months ended September 30, 2016 as compared to $607,130 or 48.4% for the nine months ended September 30, 2015, a decrease of $4,047 which was primarily due to the client lifecycle activities for the nine months ended September 30, 2016. We experienced a decrease in our product and equipment revenues as amounts for the nine months ended September 30, 2016 were $617,869 or 50.6% of total revenues, versus $648,411 or 51.6% of total revenues for nine months ended September 30, 2015. This decrease was attributed to the changes in client lifecycle activities in 2016 and increased competition from vendors as compared to the nine months ended September 30, 2015.

 

Costs of Revenues 

Costs of revenues primarily consist of labor, travel, and other costs directly attributable to providing services or products. During the nine months ended September 30, 2016, our total costs of revenues were $585,390, or 47.9% of total revenues. This compares to total costs of revenues for the nine months ended September 30, 2015 of $888,204 or 70.7% of total revenues. The decrease in costs of revenues of $302,814 was due to the changes in client activity as discussed above and a reduction in our internal infrastructure. For the nine months ended September 30, 2016, consulting-related costs were $137,920, or 11.3% of total revenue, as compared to costs of $295,659, or 23.5% of revenue for the nine months ended September 30, 2015. Costs associated with products and equipment were $447,470 or 36.6% of total revenue for the nine months ended September 30, 2016 as compared to $592,545, or 47.2% of total revenue for the nine months ended September 30, 2015. As a percentage of revenues, the decreases were primarily due to changes in client activity and vendor competition during the nine months ended September 30, 2016.

 

Gross Profit

Total gross profit was $635,562 for the nine months ended September 30, 2016, comprised of consulting services gross profit of $465,163 and products and equipment gross profit of $170,399. This compares to total gross profit of $367,337 for the nine months ended September 30, 2015, comprised of consulting services gross profit of $311,471 and products and equipment gross profit of $55,866. These increases of $153,692 for consulting services gross profit and $114,533 for products and equipment gross profit were primarily due to growth in our client base and volume of operations and further establishment of our products and equipment offerings. As a percentage of total revenues, gross profit was 52.1% for the nine months ended September 30, 2016 as compared to 29.3% for the nine months ended September 30, 2015. This increase was primarily due sales volume and client state licensing approval bonuses earned by the company during the three months ended September 30, 2016.

 

Operating Expenses

Total operating expenses were $979,194, or 80.2% of total revenues for the nine months ended September 30, 2016 as compared to $876,023, or 69.8% of total revenues for the nine months ended September 30, 2015. This increase was primarily due to an increase in general and administrative expenses as the company is incurred higher expenses for accounting fees, bad debt expense, and legal fees all attributed to costs of running a public company; the increase was also attributed to reduced labor allocations transferred out of general and administrative expenses to direct project costs (cost of revenues) for the nine months ended September 30, 2016 as compared to September 30, 2015. Also, the company has reduced selling and marketing efforts due to achieving stronger brand recognition in the market place during the nine months ended September 30, 2016 as compared with the nine months ended September 30, 2015, which has resulted in less investment in trade shows and conferences expenses. As part of the efforts on strengthening current products and services in the market in 2016, the company incurred less research and development costs for the nine months ended September 30, 2016 as compared with the nine months ended September 30, 2015.

 

 

Other Income (Expense) 

Other income (expense) for the nine months ended September 30, 2016 was an expense of $24,644 as compared with income of $46,224 for the nine months ended September 30, 2015. For the nine months ended September 30, 2016 the company incurred a non-cash interest expense reflecting $29,935 related to convertible notes payable discount amortization for the period as compared to $26,547 for the nine months ended September 30, 2015. For the nine months ended September 30, 2016 the company had income of $64,419 related to changes in derivative liabilities, while recognizing a loss on extinguishment of debt of $59,128 for the nine months ended September 30, 2016 as compared to a gain on extinguishment of debt of $72,771 for the nine months ended September 30, 2015.

 

Net Income (Loss)

As a result of the factors discussed above, net loss for the nine months ended September 30, 2016 was $368,276 or 30.2% of total revenues for the period, as compared to a net loss of $462,462, or 36.8% of total revenues for the nine months ended September 30, 2015.

 

Liquidity and Capital Resources

As of September 30, 2016, our primary internal sources of liquidity were our working capital, which included cash and cash equivalents of $71,572 and accounts receivable of $185,754. We also have the ability to raise additional capital as needed through external equity financing transactions. For the nine months ended September 30, 2016, primarily as a result of non-cash expenses, the Company’s operating cash flows were a use of $619,983 due to an increase in accounts receivable of $203,900, an increase in prepaid expenses and other current assets of $16,150 and a decrease in accrued and other current liabilities of $91,484 and a decrease in accounts payable of $117,206. These amounts were offset by decreases in Deposits of $2,845 and an increase in advances from clients of $57,326. Additionally, considering that our fixed overhead costs are low, and we have the ability to issue stock to compensate employees and management, we believe our liquidity and capital resources to be adequate to fund our general and administrative expenses. The Company will continue to explore capital raising opportunities in the future.

 

Operating Activities

Net cash used in operating activities for the nine months September 30, 2016 was $619,983 and cash provided was $98,192 for the nine months ended September 30, 2015, respectively. The $619,983 use of cash was due to loss of $368,276 for the nine months ended September 30, 2016 along with an increase in accounts receivable of $203,900 and a $117,206 decrease in accounts payable, offset by an increase in advances from clients of $57,326 and an increase in deposits of $2,845. Net cash provided by operating activities for the nine months ended September 30, 2015 was $98,192, consisting of net loss of $462,462, noncash adjustments reconciling net income to net cash provided by operating activities of $211,894 and a net source of cash of $348,760 from changes in operating assets and liabilities. The net noncash adjustments of $211,894 were due to stock-based compensation granted to service providers of $146,655, employee stock-based compensation of $102,857, amortization of the discount on convertible notes payable of $26,703, bad debt expense of $6,015, and depreciation expense of $2,435, partially offset by a gain on debt extinguishment of $72,771 related to a negotiated settlement of accumulated legal fees. Changes in operating assets and liabilities, a net source of cash of $348,760, were the result of an increase in deferred revenue of $676,144 primarily related to customer prepayments on large product and equipment orders and an increase in accounts payable of $89,472, partially offset by an increase in deposits of $193,794, an increase in accounts receivable of $138,156, an increase inventory $67,847 that primarily reflects the receipt of Satchel inventory during the period, and a decrease in accrued and other current liabilities of $1,993. 

 

Investing Activities

For the nine months ended September 30, 2016 and 2015, investing activities were a use of cash of $3,290 and $24,583, respectively. This was due to purchases of office furniture and computer equipment during the nine months ended September 30, 2016 and 2015, respectively.

 

Financing Activities

For the nine months ended September 30, 2016 and 2015, the net cash from financing activities was $139,065 and $250,000, respectively.  During the nine months ended September 30, 2016, the Company received proceeds of $139,065 from the issuance of a convertible promissory note. Net cash provided by financing activities of $250,000 for the nine months ended September 30, 2015 reflected the sale of 833,333 shares of common stock to an investor during the period.

  

Off Balance Sheet Arrangements

 

As of September 30, 2016 and December 31, 2015, we did not have any off balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources.

 

Non-GAAP Financial Measures

 

We use Adjusted EBITA, a non-GAAP metric, to monitor our overall business performance. We define Adjusted EBITA as net income (loss) before interest expense, net, provision for (benefit from) income taxes, stock-based compensation and certain non-recurring expenses, which to date have been limited to costs associated with the Reverse Merger. We believe that such adjustments to arrive at Adjusted EBITA provides us with a more comparable measure for managing our business. We also believe that it is a useful measure for securities analysts, investors, and other interested parties in the evaluation of our Company.

 

A reconciliation of net loss to Adjusted EBITA is provided below:

  For the three months ended September 30, 2016 For the three months ended September 30, 2015   For the nine months ended September 30, 2016 For the nine months ended September 30, 2015
Adjusted EBITA reconciliation:          
   Net loss  $                (269,944)  $          (192,010)    $         (368,276)  $              (462,462)
   Loss (Gain) on debt Extinguishment                 59,128                         —           59,128                (72,771)
   Interest expense, net 19,605 8,924   29,935 26,547
   Derivative Liabilities (64,419) —   (64,419) —
   Tax expense (benefit) — —   — —
   Stock-based compensation expense 1,818 61,733   16,240 249,512
                 Adjusted EBITA  $                (253,812)  $          (121,353)    $         (327,392)  $              (259,174)

ITEM 3. QUANTITATIVE & QUALITATIVE DISCLOSURES ABOUT MARKET RISK

 

 We are a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item.

 

 

ITEM 4. CONTROLS AND PROCEDURES

 

Management of the Company is responsible for maintaining disclosure controls and procedures that are designed to ensure that financial information required to be disclosed in the reports that the Company files or submits under the Securities Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the timeframes specified in the Securities and Exchange Commission’s rules and forms, consistent with Items 307 and 308 of Regulation S-K.

 

In addition, the disclosure controls and procedures must ensure that such financial information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required financial and other required disclosures.

 

As of September 30, 2016, an evaluation of the effectiveness of the Company’s disclosure controls and procedures (as defined in Rules 13(a)-15(e) and 15(d)-15(e) of the Securities Exchange Act of 1934 (the “Exchange Act”) was carried out under the supervision and with the participation of our Chief Executive Officer, Chief Financial Officer, and other persons carrying out similar functions for the Company. Based on the evaluation of the Company’s disclosure controls and procedures, the Company concluded that during the period covered by this report, such disclosure controls and procedures were not effective.

 

The Company continues to employ and refine a structure in which critical accounting policies, issues and estimates are identified, and together with other complex areas, are subject to multiple reviews by accounting personnel. In addition, the Company evaluates and assesses its internal controls and procedures regarding its financial reporting, utilizing standards incorporating applicable portions of the Public Company Accounting Oversight Board’s 2009 Guidance for Smaller Public Companies in Auditing Internal Controls Over Financial Reporting as necessary and on an on-going basis.

 

Because of its inherent limitations, internal control over financial reporting cannot provide absolute assurance of the prevention or detection of misstatements. In addition, projections of any evaluation of effectiveness to future periods are subject to risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Changes in Internal Controls

 

 

The Company had no reportable changes to its internal controls over financial reporting for the period covered by this report. 

 

The Company will continually enhance and test its internal controls over financial reporting on a continuing basis. Additionally, the Company’s management, under the control of its Chief Executive Officer and Chief Financial Officer, will increase its review of its disclosure controls and procedures on an ongoing basis. Finally, the Company plans to designate, in conjunction with its Chief Financial Officer, individuals responsible for identifying reportable developments and the process for resolving compliance issues related to them. The Company believes these actions will focus necessary attention and resources in its internal accounting functions. 

 

 

 

PART II—OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

On January 20, 2016, the Company was named as a defendant in a civil suit entitled: Anthony Baroud vs. Hollister & Blacksmith, Inc., dba American Cannabis Company filed in the Circuit Court of Cook County, Illinois. The lawsuit sought damages of $100,000 related to an employment contract. The Company filed a motion to dismiss the case based upon the employment contract, which required mandatory contractual arbitration of disputes. On May 18, 2016 the Circuit Court of Cook County, Illinois granted the Company’s motion and the case was dismissed. On November 1, 2016, the Company received notice of a demand for arbitration filed with the American Arbitration Association by Mr. Baroud on October 27, 2016. The Company has yet to receive a copy of Mr. Baroud’s arbitration claim.

 

ITEM 1A. RISK FACTORS

 

We are a smaller reporting Company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information required under this item. 

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

No transactions meeting the reporting requirements of this item occurred during the periods covered by this report.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

No senior securities were issued and outstanding during the three and nine months ended September 30, 2016 or 2015.

 

ITEM 5. OTHER INFORMATION

 

None.

 

 

 

ITEM 6. EXHIBITS

 

This list is intended to constitute the exhibit index.

 

10.1Amended and Restated Investment Agreement dated August 4, 2016 between the Company and Tangiers Global, LLC.

 

10.2Amended and Restated Registration Rights Agreement dated August 4, 2016 between the Company and Tangiers Global, LLC.

31.1   Certification of Principal Executive Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2   Certification of Principal Financial Officer as required by Rule 13a-14 or 15d-14 of the Exchange Act, as adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32.1   Certification of Principal Executive Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
32.2   Certification of Principal Financial Officer Pursuant to 18 U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS   XBRL Instance Document*
101.SCH   XBRL Taxonomy Extension Schema Document*
101.CAL   XBRL Taxonomy Extension Calculation Linkbase Document*
101.DEF   XBRL Taxonomy Extension Definition Linkbase Document*
101.LAB   XBRL Taxonomy Extension Label Linkbase Document*

*Pursuant to Rule 406T of Regulation S-T, these interactive data files are deemed not filed or part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933 or Section 18 of the Securities and Exchange Act of 1934, and otherwise are not subject to liability under those sections.

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    American Cannabis Company, Inc.
     
Date: November 16, 2016   By: /s/ Corey Hollister
    Corey Hollister,
    Chief Executive Officer
    (Principal Executive Officer)
     
Date: November 16, 2016   By: /s/ Jesus Quintero
    Jesus Quintero,
    Chief Financial Officer
    (Principal Accounting Officer)